Literature DB >> 22438089

Coronary artery spasm and ventricular arrhythmias.

Khang Li Looi1, Andrew Grace, Sharad Agarwal.   

Abstract

Coronary artery spasm (CAS) is characterised by chest pain at rest and transient ST segment elevation on the ECG. The natural history of variant angina is not fully understood. Patients with CAS are younger, mostly female subjects and usually do not have traditional cardiovascular risk factors other than cigarette smoking. Cardiac arrhythmias are known to be associated with CAS. Ventricular arrhythmia is a well-recognised complication and sudden cardiac death has also been documented. The most important diagnostic tool in CAS is coronary angiography. 24 h ECG Holter monitoring can be very useful in the diagnosis of ventricular arrhythmias caused by CAS. The mainstay therapy for CAS is calcium channel blockers and nitrates. The use of β-blockers, especially the non-selective group, can promote attacks or prolong vasospastic state. The indication for implantable cardioverter defibrillator (ICD) implantation in a patient with CAS is still not clearly established. The role of primary prevention with the use of ICD is controversial; however, ICD implantation should be considered in high risk patients despite optimal medical treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22438089     DOI: 10.1136/postgradmedj-2011-130494

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  3 in total

1.  Syncope caused by coronary artery spasm without chest pain leading to ventricular fibrillation.

Authors:  Yusuke Kawasaki; Takao Kato; Eri Minamino; Moriaki Inoko
Journal:  BMJ Case Rep       Date:  2013-06-06

2.  Ventricular arrhythmias not meeting criteria for terminating cardiopulmonary exercise testing stratify prognosis and disease severity in heart failure of preserved, midrange, and reduced ejection fraction.

Authors:  Dejana Popovic; Ross Arena; Djordje Jakovljevic; Arsen Ristic; Marco Guazzi
Journal:  Clin Cardiol       Date:  2020-04-09       Impact factor: 2.882

3.  Consumption of energy beverage is associated with attenuation of arterial endothelial flow-mediated dilatation.

Authors:  John P Higgins; Benjamin Yang; Nikki E Herrin; Santi Yarlagadda; George T Le; Brandon L Ortiz; Asif Ali; Stephen C Infanger
Journal:  World J Cardiol       Date:  2017-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.